The Think Tank on Advancing Precision Medicine in Rare Cancers is a highly interactive meeting that brings together clinicians, researchers, industry representatives, advocates, and patients to collaborate on common challenges in rare cancer research and treatment.
Leveraging the successful Think Tank model established through over a decade of TargetCancer Foundation meetings, it creates a collaborative environment where diverse perspectives and ideas thrive. This meeting also builds on the progress made through TargetCancer Foundation’s TCF-001 TRACK study, a nationwide, decentralized, patient-driven clinical trial studying precision medicine in rare cancers.
2025 Think Tank on Advancing Precision Medicine in Rare Cancers
October 29, 2025 | State Room, Boston, MA
8:00 AM- 5:00 PM
Reception to follow
Registration will open soon- please check this page for updates.
*Please note that this meeting is being held in-person only- there is no option to participate virtually.
Call for Abstracts
Encouraging Early Career Investigators to Make a Difference in Rare Cancers
TargetCancer Foundation is pleased to invite early investigators (within 5 years of fellowship or terminal degree) from local universities, medical, and scientific institutions to submit abstracts for the upcoming Think Tank. Abstract topics must be on research focused on rare cancers, including but not limited to clinical, translational, epidemiological, and basic science studies.
The submission deadline is July 31, 2025.
Agenda
Scientific Keynote Speaker
Dr. Andrea Cercek
Section Head, Colorectal Cancer
Co-Director, Center for Young Onset Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Full agenda is coming soon.
Venue
The 2025 Think Tank on Advancing Precision Medicine in Rare Cancers will be held at the State Room, located at 60 State Street in Boston, MA. The venue is centrally located downtown and easily accessible via public transport.
Accommodations
Details and a booking link for our room block at The Bostonian Hotel will be shared soon.
Thank You To Our Sponsors
What participants are saying
This was a fantastic #RareCancer #PrecisionMedicine meeting @targetcancer in Boston! So much enthusiasm from patients and patient advocates to move the field forward.
Vivek Subbiah, MD
Sarah Cannon Research Institute
Originally posted on Twitter
This is genuinely the best rare cancer meeting I have ever attended.
Razelle Kurzrock, MD
Froedtert and Medical College of Wisconsin
…thank you for allowing me to be a part of the discussion of challenges, goals, opportunities and best practices in addressing the needs of patients facing rare cancers. What a wonderful group of humans you gathered. I was so inspired.
Katie Ortman Doble
Patient Keynote Speaker,
2023 Think Tank on Advancing Precision Medicine in Rare Cancers
View and download materials from past meetings
TCF-001 TRACK Live Molecular Tumor Board 2023: Osteosarcoma
We are grateful to our industry partners for supporting these meetings and for their dedication to developing treatments for patients with rare cancers.